Yamakawa-Kobayashi Kimiko, Yanagi Hisako, Yu YuXing, Endo Kazue, Arinami Tadao, Hamaguchi Hideo
Department of Medical Genetics, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan.
Metabolism. 2004 Feb;53(2):182-6. doi: 10.1016/j.metabol.2003.08.009.
ATP-binding cassette transporter A1 (ABCA1) plays an important role in apolipoprotein AI (apoAI)-mediated cholesterol efflux from peripheral cells. The mild changes in ABCA1 activity due to genomic variation might be associated with interindividual variations in serum high-density lipoprotein cholesterol (HDL-C) and apoAI levels, or primary hypoalphalipoproteinemia in the general population. In the present study, we analyzed the relationships between 5 single nucleotide polymorphisms (SNPs) and 2 insertion/deletion polymorphisms in the 5' flanking region and 5 missense polymorphisms of the ABCA1 gene and serum lipid levels in healthy school-aged children. We detected significant associations between the K219R and V771M polymorphisms, and HDL-C or apoAI levels. The present data support the proposition that the K219 allele is an anti-atherogenic allele with increased cholesterol efflux activity. Similarly, the M771 allele appears to be anti-atherogenic, although the frequency of the M771 allele is low.
ATP结合盒转运体A1(ABCA1)在载脂蛋白AI(apoAI)介导的外周细胞胆固醇流出过程中发挥重要作用。由于基因变异导致的ABCA1活性的轻微变化可能与血清高密度脂蛋白胆固醇(HDL-C)和apoAI水平的个体差异,或普通人群中的原发性低α脂蛋白血症有关。在本研究中,我们分析了ABCA1基因5'侧翼区域的5个单核苷酸多态性(SNP)和2个插入/缺失多态性以及5个错义多态性与健康学龄儿童血脂水平之间的关系。我们检测到K219R和V771M多态性与HDL-C或apoAI水平之间存在显著关联。目前的数据支持K219等位基因是具有增强胆固醇流出活性的抗动脉粥样硬化等位基因这一观点。同样,M771等位基因似乎也具有抗动脉粥样硬化作用,尽管M771等位基因的频率较低。